A Dermatologist's Guide to Infection Screening Prior to Initiating Immunosuppressive Therapy.

Area of Science:

• Dermatology
• Immunology
• Infectious Diseases

Background:

• Immunosuppressant medications are vital for managing chronic dermatological conditions like psoriasis and autoimmune bullous diseases.
• Therapy with these agents carries a significant risk of secondary infections.
• Awareness of potential sequelae is crucial for safe patient management.

Purpose of the Study:

• To review common immunosuppressant medications used in dermatology.
• To highlight the risk of infections associated with these treatments.
• To provide recommendations for pre-treatment infection screening.

Main Methods:

• Literature review of current immunosuppressant therapies in dermatology.
• Analysis of infection risks associated with commonly prescribed agents.
• Development of guidelines for pre-treatment screening protocols.

Main Results:

• Identification of key immunosuppressants utilized in dermatological practice.
• Summary of the spectrum of infections associated with immunosuppression.
• Establishment of evidence-based recommendations for screening.

Conclusions:

• Immunosuppressive therapy requires careful patient selection and monitoring.
• Proactive infection screening before initiating treatment is essential.
• Implementing screening protocols can mitigate treatment-related infectious complications.